Sonpal Singh
Sonpal Singh
20 hours ago
Share:

Global Neuroscience Market Outlook 2033: Size, Trends & Opportunities

The global neuroscience market size reached USD 35.9 Billion in 2024 and grow at a CAGR of 3.1% to reach USD 48.0 Billion by 2033.

The global Neuroscience market size was valued at USD 35.9 Billion in 2024 and is anticipated to reach USD 48.0 Billion by 2033, exhibiting a CAGR of 3.1% during the forecast period 2025-2033. Market growth is driven by increasing prevalence of neurological disorders, significant investments in research and development, and technological advancements in neuroimaging tools. The expanding applications in neuroinformatics, rising aging populations, and supportive government policies further support the growth of this market. 

Study Assumption Years

  • Base Year: 2024
  • Historical Year/Period: 2019-2024
  • Forecast Year/Period: 2025-2033

Neuroscience Market Key Takeaways

  • Current Market Size: USD 35.9 Billion in 2024
  • CAGR: 3.1% during 2025-2033
  • Forecast Period: 2025-2033
  • Increasing prevalence of neurological disorders including epilepsy and Alzheimer's is a major market driver.
  • Technological advancements in neuroimaging and diagnostics, such as AI-powered systems, are fueling market growth.
  • Growth is supported by rising investment in R&D from both public institutions and private enterprises.
  • North America currently leads the market due to extensive R&D investments and a well-established healthcare system.
  • The Asia Pacific region is the fastest-growing market, driven by increased healthcare spending and governmental initiatives such as China's China Brain Project.

Sample Request Link:

 https://www.imarcgroup.com/neuroscience-market/requestsample

Market Growth Factors

Increasing Prevalence of Neurological Disorders

The global rise in neurological conditions such as Alzheimer’s disease, Parkinson’s disease, and epilepsy is significantly driving neuroscience market growth. Alzheimer's cases are projected to reach 13 Million in the US by 2050. The aging population increases susceptibility to these disorders, resulting in rising demand for advanced diagnostics and treatments. The hospital sector is expected to observe the fastest growth due to increasing neurological admissions and expanded healthcare infrastructure.

Rising Investment in Neuroscience Research and Development

The field sees strong funding surges from both the public and private sectors. Investments span fundamental brain research and advanced technologies such as brain mapping and neural data integration. Key players in biotech and pharma are developing new drugs and therapies. Enhanced consumables like user-friendly patient monitors and injectors by companies such as B. Braun SE and GE Healthcare improve neurological care efficiency, accelerating scientific discovery and its clinical application.

Technological Advancements in Neuroimaging Tools

Neuroimaging technologies including MRI, PET, and EEG offer higher resolution, faster imaging, and improved data analysis through advanced algorithms. The innovations allow earlier and more precise detection and localization of brain abnormalities critical for effective treatment. Emerging neuro-microscopy with ultra-miniature electronic microscopes, developed by Danaher Corporation and Carl Zeiss AG, also aims to detect and potentially reverse neurological damage, thus expanding the capabilities of neuroscience research and clinical practice.

Market Segmentation

Breakup by Component:

  • Instruments and Consumables: This largest segment grows due to demand for advanced diagnostic and surgical tools, enhanced efficiency with precision instruments and disposable consumables, and regulatory mandates supporting certified and sterile products.
  • Software and Services

Breakup by Technology:

  • Brain Imaging: Holds the majority share. Driven by the need for advanced diagnostics amid rising neurological disorders, supported by improvements in MRI, PET, CT imaging modalities and AI/ML integrations.
  • Neuro-Microscopy
  • Electrophysiology
  • Neuroproteomic Analysis
  • Animal Behaviour Analysis
  • Others

Breakup by End User:

  • Hospitals: Fastest growth driven by demand for specialized services, advanced technologies, and expanded infrastructure, improving patient outcomes and care quality.
  • Diagnostic Laboratories: Growth due to increasing need for early, accurate diagnosis employing molecular diagnostics, next-generation sequencing, and advanced imaging.
  • Research and Academic Institutes: Expansion from increased scientific research and collaborations supporting development of new therapies, clinical trials, and translational research.
  • Others

Breakup by Region:

  • North America: Largest market share, driven by high prevalence of chronic diseases, advanced healthcare systems, and significant device development sectors.
  • Asia Pacific: Fastest growth fueled by healthcare infrastructure investment and governmental initiatives like China Brain Project.
  • Europe
  • Latin America
  • Middle East and Africa

Regional Insights

North America dominates the neuroscience market, accounting for the largest market share. This leadership is attributed to substantial investments in research and development, a high incidence of neurological disorders, and a well-established healthcare infrastructure. The United States serves as a hub for companies and research institutions that drive innovation and market growth. The Asia Pacific region is the fastest-growing market, supported by improved healthcare spending and government initiatives such as China's USD 746 Million China Brain Project launched in 2022.

Recent Developments & News

In 2021, Blackrock Neurotech announced a breakthrough with its wireless brain-computer interface (BCI) system, enabling real-time neural activity monitoring without wired connections, enhancing patient comfort during studies. In 2022, Kernel introduced Kernel Flow, a non-invasive brain recording device using time-domain functional near-infrared spectroscopy (TD-fNIRS) technology to capture brain activity with high spatial and temporal resolution, broadening applications in clinical and consumer neuroscience.

Key Players

  • Alpha Omega Engineering
  • Biobserve GmbH
  • Blackrock Neurotech
  • Doric Lenses Inc.
  • General Electric Company
  • Kernel
  • Laserglow Technologies
  • Mightex Systems
  • NeuroNexus Technologies Inc.
  • Noldus Information Technology B.V.
  • Plexon Inc.
  • Prizmatix Ltd.
  • Siemens AG

Get Custom Market Research Report for Your Business:

https://www.imarcgroup.com/request?type=report&id=5133&flag=E

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

Tel No: (D) +91 120 433 0800,

United States: +1-201971-6302